Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Biocon Ltd.
NSE: BIOCON
|
BSE: 532523
|
ISIN: INE376G01013
|
Industry: Biotechnology
|
Strong Performer, Getting Expensive
390.4500
11.35
(
2.99
%)
NSE
Jul 15, 2025
15:31 PM
Near 52W High of ₹404.70
Volume:
7.8M
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Biocon Ltd.
09 Nov 2018
390.45
2.99%
Model Trading Portfolio | Buy Biocon Ltd
Buy:
Biocon Ltd.
by
Edelweiss
Edelweiss
Biocon Limited is an Indian biopharmaceutical company based in Bangalore, India.
Biocon Ltd. has an
average target
of 389.25 from 4 brokers.
More from Biocon Ltd.
Recommended
Five stocks to buy from analysts this week - July 15, 2025
The Baseline |
15 Jul 2025, 06:44PM
Market closes higher, ICICI Prudential's Q1 net profit surges 34.2% YoY to Rs 301 crore
Trendlyne Marketwatch |
15 Jul 2025, 03:56PM
A long drawn out R&D plan may be finally paying off for Biocon
|
20 Aug 2020